Rare diseases: Innovation, collaboration, and genomics
|
Health Europa
|
Professor Hackett discusses public-private collaboration, secure data sharing and the potential of genomic sequencing for the treatment of rare diseases. Professor Joanne Hackett, General Partner, Healthcare at early stage venture and growth stage advisory firm Izy Capital, joined the company from Genomics England, where she oversaw industry engagement and commercial collaboration.
|
|
|